Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar 16;9(3):364.
doi: 10.3390/jof9030364.

Importance of Clinical Isolates in Cryptococcus neoformans Research

Affiliations
Review

Importance of Clinical Isolates in Cryptococcus neoformans Research

Katrina M Jackson et al. J Fungi (Basel). .

Abstract

The human pathogenic fungus Cryptococcus neoformans is a global health concern. Previous research in the field has focused on studies using reference strains to identify virulence factors, generate mutant libraries, define genomic structures, and perform functional studies. In this review, we discuss the benefits and drawbacks of using reference strains to study C. neoformans, describe how the study of clinical isolates has expanded our understanding of pathogenesis, and highlight how studies using clinical isolates can further develop our understanding of the host-pathogen interaction during C. neoformans infection.

Keywords: Cryptococcus neoformans; clinical isolates; genotype; host–pathogen interaction.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
References strains, clinical isolates, and environmental isolates are beneficial for studying various aspects of Cryptococcus biology.
Figure 2
Figure 2
Experimental strategy to study host–pathogen interactions using C. neoformans clinical isolates.

References

    1. Altamirano S., Jackson K.M., Nielsen K. The interplay of phenotype and genotype in Cryptococcus neoformans disease. Biosci. Rep. 2020;40:BSR20190337. doi: 10.1042/BSR20190337. - DOI - PMC - PubMed
    1. Rajasingham R., Smith R.M., Park B.J., Jarvis J.N., Govender N.P., Chiller T.M., Denning D.W., Loyse A., Boulware D.R. Global burden of disease of HIV-associated cryptococcal meningitis: An updated analysis. Lancet Infect. Dis. 2017;17:873–881. doi: 10.1016/S1473-3099(17)30243-8. - DOI - PMC - PubMed
    1. Tenforde M.W., Gertz A.M., Lawrence D.S., Wills N.K., Guthrie B.L., Farquhar C., Jarvis J.N. Mortality from HIV-associated meningitis in sub-Saharan Africa: A systematic review and meta-analysis. J. Int. AIDS Soc. 2020;23:e25416. doi: 10.1002/jia2.25416. - DOI - PMC - PubMed
    1. Jarvis J.N., Lawrence D.S., Meya D.B., Kagimu E., Kasibante J., Mpoza E., Rutakingirwa M.K., Ssebambulidde K., Tugume L., Rhein J., et al. Single-dose liposomal amphotericin B treatment for cryptococcal meningitis. N. Engl. J. Med. 2022;386:1109–1120. doi: 10.1056/NEJMoa2111904. - DOI - PMC - PubMed
    1. Boulware D.R., Meya D.B., Muzoora C., Rolfes M.A., Huppler Hullsiek K., Musubire A., Taseera K., Nabeta H.W., Schutz C., Williams D.A., et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. N. Engl. J. Med. 2014;370:2487–2498. doi: 10.1056/NEJMoa1312884. - DOI - PMC - PubMed

LinkOut - more resources